| |
original article |
Date |
Title |
Authors Max. 6 Authors |
| 1 |
[GO] |
2022―Nov―28 |
Clinical research reactivation during the COVID-19 pandemic: An academic center process and lessons for the future |
Jennifer Armstrong, Alison Lakin, Laurie Blumberg-Romero, Thomas Campbell, John Heldens, Christopher Lieu, Jenae Neiman, Erin Sandene, Matthew Steinbeiss, Darcy Thompson, Jason Tregellas, Thomas Flaig, Janine Higgins |
| 2 |
[GO] |
2022―Aug―05 |
Breastfeeding rates in the Covid-19 era: The experience of a Greek “Baby Friendly Hospital” |
Theodora Boutsikou, Zoi Iliodromiti, Abraham Pouliakis, Alma Soulai, Leoni Tzounakou, Paraskevi Volaki, Chrysoula Petropoulou, Rozeta Sokou, Nicoletta Iacovidou |
| 3 |
[GO] |
2022―Aug―05 |
Implications of the novel mutations in the SARS-CoV-2 genome for transmission, disease severity and the vaccine development |
Hikmet Akkiz |
| 4 |
[GO] |
2022―Aug―05 |
Biological and radiological biomarkers in SARS-CoV-2 infected healthcare workers in governmental hospitals in Qatar |
Rahman M U A, Prabhu KS, Raza A, Elmi M, Mahmood N, Shah MH, Abid FB, Dermime S, Uddin S, Al Maslamani M, Mohamed Ibrahim MI |
| 5 |
[GO] |
2022―Aug―05 |
The occurrence of antibody dependent enhancement (ADE) in SARS-CoV-2 infection: implications for treatment |
Maurizio Guastalegname, Laura D’argenio, Alfredo Vallone |
| 6 |
[GO] |
2021―Sep―13 |
The half-life of truth in medicine regarding the Covid-19 disease |
Caroline Bastid, Jean Louis Frossard |
| 7 |
[GO] |
2021―Jul―07 |
Virtual reality hypnosis improves sleep quality of first-line medical staff responding to COVID-19 |
Guo Zhongwei, Duan Xin, Wang Lijuan, Zheng Jisheng, Lu Longxi |
| 8 |
[GO] |
2021―Jul―07 |
Vinegar and its active component acetic acid inhibit SARS-CoV-2 infection in vitro and ex vivo |
Isabel Pagani, Silvia Ghezzi, Massimo Clementi, Guido Poli, Mario Bussi, Luca Pianta, Matteo Trimarchi, Elisa Vicenzi |
| 9 |
[GO] |
2021―Jul―07 |
SARS-CoV-2: Endoscopy procedures at risk of airborne particles transmission |
Frossard JL, Negro F |
| 10 |
[GO] |
2021―Feb―19 |
ACE DD polymorphism in severe COVID-19 |
Anna Annunziata, Antonietta Coppola, Maurizia Lanza, Francecsa Simioli, Pasquale Imitazione, Nicola Pepe, Valeria Maddaloni, Luigi Atripaldi, Giuseppe Fiorentino |
| 11 |
[GO] |
2021―Feb―19 |
A novel functional beverage for COVID-19 and other conditions: Hypothesis and preliminary data, increased blood flow, and wound healing |
LeBaron TW, McCullough ML, Ruppman Sr KH |
| 12 |
[GO] |
2021―Feb―19 |
Pharmacological approaches to the treatment of COVID-19 patients |
Lawrence C. Sowers, Lucas S. Blanton, Scott C Weaver, Randall J. Urban, Charles P. Mouton |
| 13 |
[GO] |
2021―Feb―19 |
Sedeprovid, a novel vitamin D based substance, plus AlphaH℗ lead to complete recovery from COVID-19 within 48 hours after application in a 7-months old baby, a 1.5-year-old toddler and three further adults |
Herwig R, Panhofer TP, Greilberger M, Greilberger J |
| 14 |
[GO] |
2021―Feb―19 |
Proposed mechanism for anosmia during COVID-19: The role of local zinc distribution |
Ozlem Equils, Klaudi Lekaj, Sahar Fattani, Arthur Wu, Gene Liu |
| 15 |
[GO] |
2021―Feb―19 |
COVID-19: The third wave of coronavirus infection outbreak |
Sokolovska L, Sultanova A, Cistjakovs M, Murovska M |
|
